Adults who achieve type 2 diabetes remission are less likely to develop chronic kidney disease and cardiovascular disease, according to study findings published in Diabetologia.

- In a landmark study, the Look AHEAD trial reveals a significant health breakthrough for individuals with type 2 diabetes. 
- Over a 12-year period, participants who achieved any form of diabetes remission—defined as no diabetes medication with HbA1c levels below 6.5%—exhibited a remarkable reduction in chronic kidney disease (CKD) and cardiovascular disease (CVD) incidences. 
- Specifically, those in remission had a 33% lower rate of CKD and a 40% decrease in CVD occurrences compared to those without remission. 

These findings underline the profound impact of diabetes remission on reducing major health risks, emphasizing the importance of intensive lifestyle interventions in diabetes management. 

Source: Diabetologia | [Read full story](https://link.springer.com/article/10.1007/s00125-023-06048-6)